ID

15960

Beschrijving

Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission; ODM derived from: https://clinicaltrials.gov/show/NCT02373813

Link

https://clinicaltrials.gov/show/NCT02373813

Trefwoorden

Versies (1)
  1. 21-06-16 21-06-16 -
Geüploaded op

21 juni 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Rheumatoid Arthritis NCT02373813

Engels

Eligibility Rheumatoid Arthritis NCT02373813

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
subjects must be adults with a history of moderate to severe rheumatoid arthritis;
Beschrijving

Adult | Rheumatoid Arthritis Moderate | Rheumatoid Arthritis Severe

Datatype

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2,1]
C0003873
UMLS CUI [2,2]
C0205081
UMLS CUI [3,1]
C0003873
UMLS CUI [3,2]
C0205082
subjects must be in very good rheumatoid arthritis disease control for ≥ 6 months and be in remission as defined by a simplified disease activity index ≤ 3.3 at screening and at the end of the run-in period.
Beschrijving

Rheumatoid Arthritis | Disease control Very good | Simplified disease activity index

Datatype

boolean

Alias
UMLS CUI [1]
C0003873
UMLS CUI [2,1]
C0920467
UMLS CUI [2,2]
C3641222
UMLS CUI [3]
C3869582
subjects must be on etanercept plus methotrexate therapy for ≥ 6 months prior to the start of the run-in period. the methotrexate dose must be 10 to 25 mg per week for ≥
Beschrijving

Therapeutic procedure Etanercept Methotrexate

Datatype

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0717758
UMLS CUI [1,3]
C0025677
6 months prior to the start of the run-in period and the dose must be stable for ≥ 8 weeks prior to the start of the run-in period.
Beschrijving

Methotrexate Dosage Stable

Datatype

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
subject has no known history of active tuberculosis, and has a negative test for tuberculosis during screening.
Beschrijving

Active tuberculosis Absent | Tuberculosis test negative

Datatype

boolean

Alias
UMLS CUI [1,1]
C0151332
UMLS CUI [1,2]
C0332197
UMLS CUI [2]
C2242735
exclusion criteria:- subject has used biologic disease modifying antirheumatic drug other than etanercept or has used an oral janus kinase inhibitor ≤ 6 months prior to run-in visit 1
Beschrijving

Exclusion Criteria | Antirheumatic Drugs, Disease-Modifying | Etanercept | Janus kinase inhibitor Oral

Datatype

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0242708
UMLS CUI [3]
C0717758
UMLS CUI [4,1]
C3854325
UMLS CUI [4,2]
C1527415
subject has any active infection (including chronic or localized infections) for which anti-infectives were indicated within 4 weeks prior to run-in visit 1.
Beschrijving

Communicable Diseases | Chronic infectious disease | Focal Infection | Indication Anti-Infective Agents

Datatype

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2]
C0151317
UMLS CUI [3]
C0016397
UMLS CUI [4,1]
C3146298
UMLS CUI [4,2]
C0003204
subject has known alcohol addiction or dependency or uses alcohol daily.
Beschrijving

Alcohol dependence

Datatype

boolean

Alias
UMLS CUI [1]
C0001973
subject has one or more significant concurrent medical conditions per investigator judgment, including the following:
Beschrijving

Comorbidity

Datatype

boolean

Alias
UMLS CUI [1]
C0009488
poorly controlled diabetes
Beschrijving

Diabetes mellitus poor control

Datatype

boolean

Alias
UMLS CUI [1]
C0860161
chronic kidney disease stage iiib, iv, or v
Beschrijving

Chronic Kidney Diseases | chronic kidney disease stage

Datatype

boolean

Alias
UMLS CUI [1]
C1561643
UMLS CUI [2]
C2074731
symptomatic heart failure (new york heart association class ii, iii, or iv)
Beschrijving

Heart failure Symptomatic | New York Heart Association Classification

Datatype

boolean

Alias
UMLS CUI [1,1]
C0018801
UMLS CUI [1,2]
C0231220
UMLS CUI [2]
C1275491
myocardial infarction or unstable angina pectoris within the past 12 months prior to randomization
Beschrijving

Myocardial Infarction | Angina, Unstable

Datatype

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0002965
uncontrolled hypertension
Beschrijving

Uncontrolled hypertension

Datatype

boolean

Alias
UMLS CUI [1]
C1868885
severe chronic pulmonary disease (eg, requiring oxygen therapy)
Beschrijving

Severe chronic obstructive pulmonary disease | Oxygen Therapy Required

Datatype

boolean

Alias
UMLS CUI [1]
C0730607
UMLS CUI [2,1]
C0184633
UMLS CUI [2,2]
C1514873
multiple sclerosis or any other demyelinating disease
Beschrijving

Multiple Sclerosis | Demyelinating Disease

Datatype

boolean

Alias
UMLS CUI [1]
C0026769
UMLS CUI [2]
C0011303
major chronic inflammatory disease or connective tissue disease other than rheumatoid arthritis (eg, systemic lupus erythematosus with the exception of secondary sjögren's syndrome)
Beschrijving

Chronic inflammatory disorder Major | Connective Tissue Diseases | Rheumatoid Arthritis | Lupus Erythematosus, Systemic | Sjogren's Syndrome Secondary

Datatype

boolean

Alias
UMLS CUI [1,1]
C1290886
UMLS CUI [1,2]
C0205164
UMLS CUI [2]
C0009782
UMLS CUI [3]
C0003873
UMLS CUI [4]
C0024141
UMLS CUI [5,1]
C1527336
UMLS CUI [5,2]
C0175668
Terug naar het begin van de pagina

Similar models

Eligibility Rheumatoid Arthritis NCT02373813

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Rheumatoid Arthritis Moderate | Rheumatoid Arthritis Severe
Item
subjects must be adults with a history of moderate to severe rheumatoid arthritis;
boolean
C0001675 (UMLS CUI [1])
C0003873 (UMLS CUI [2,1])
C0205081 (UMLS CUI [2,2])
C0003873 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
Rheumatoid Arthritis | Disease control Very good | Simplified disease activity index
Item
subjects must be in very good rheumatoid arthritis disease control for ≥ 6 months and be in remission as defined by a simplified disease activity index ≤ 3.3 at screening and at the end of the run-in period.
boolean
C0003873 (UMLS CUI [1])
C0920467 (UMLS CUI [2,1])
C3641222 (UMLS CUI [2,2])
C3869582 (UMLS CUI [3])
Therapeutic procedure Etanercept Methotrexate
Item
subjects must be on etanercept plus methotrexate therapy for ≥ 6 months prior to the start of the run-in period. the methotrexate dose must be 10 to 25 mg per week for ≥
boolean
C0087111 (UMLS CUI [1,1])
C0717758 (UMLS CUI [1,2])
C0025677 (UMLS CUI [1,3])
Methotrexate Dosage Stable
Item
6 months prior to the start of the run-in period and the dose must be stable for ≥ 8 weeks prior to the start of the run-in period.
boolean
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Active tuberculosis Absent | Tuberculosis test negative
Item
subject has no known history of active tuberculosis, and has a negative test for tuberculosis during screening.
boolean
C0151332 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C2242735 (UMLS CUI [2])
Exclusion Criteria | Antirheumatic Drugs, Disease-Modifying | Etanercept | Janus kinase inhibitor Oral
Item
exclusion criteria:- subject has used biologic disease modifying antirheumatic drug other than etanercept or has used an oral janus kinase inhibitor ≤ 6 months prior to run-in visit 1
boolean
C0680251 (UMLS CUI [1])
C0242708 (UMLS CUI [2])
C0717758 (UMLS CUI [3])
C3854325 (UMLS CUI [4,1])
C1527415 (UMLS CUI [4,2])
Communicable Diseases | Chronic infectious disease | Focal Infection | Indication Anti-Infective Agents
Item
subject has any active infection (including chronic or localized infections) for which anti-infectives were indicated within 4 weeks prior to run-in visit 1.
boolean
C0009450 (UMLS CUI [1])
C0151317 (UMLS CUI [2])
C0016397 (UMLS CUI [3])
C3146298 (UMLS CUI [4,1])
C0003204 (UMLS CUI [4,2])
Alcohol dependence
Item
subject has known alcohol addiction or dependency or uses alcohol daily.
boolean
C0001973 (UMLS CUI [1])
Comorbidity
Item
subject has one or more significant concurrent medical conditions per investigator judgment, including the following:
boolean
C0009488 (UMLS CUI [1])
Diabetes mellitus poor control
Item
poorly controlled diabetes
boolean
C0860161 (UMLS CUI [1])
Chronic Kidney Diseases | chronic kidney disease stage
Item
chronic kidney disease stage iiib, iv, or v
boolean
C1561643 (UMLS CUI [1])
C2074731 (UMLS CUI [2])
Heart failure Symptomatic | New York Heart Association Classification
Item
symptomatic heart failure (new york heart association class ii, iii, or iv)
boolean
C0018801 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C1275491 (UMLS CUI [2])
Myocardial Infarction | Angina, Unstable
Item
myocardial infarction or unstable angina pectoris within the past 12 months prior to randomization
boolean
C0027051 (UMLS CUI [1])
C0002965 (UMLS CUI [2])
Uncontrolled hypertension
Item
uncontrolled hypertension
boolean
C1868885 (UMLS CUI [1])
Severe chronic obstructive pulmonary disease | Oxygen Therapy Required
Item
severe chronic pulmonary disease (eg, requiring oxygen therapy)
boolean
C0730607 (UMLS CUI [1])
C0184633 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
Multiple Sclerosis | Demyelinating Disease
Item
multiple sclerosis or any other demyelinating disease
boolean
C0026769 (UMLS CUI [1])
C0011303 (UMLS CUI [2])
Chronic inflammatory disorder Major | Connective Tissue Diseases | Rheumatoid Arthritis | Lupus Erythematosus, Systemic | Sjogren's Syndrome Secondary
Item
major chronic inflammatory disease or connective tissue disease other than rheumatoid arthritis (eg, systemic lupus erythematosus with the exception of secondary sjögren's syndrome)
boolean
C1290886 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C0009782 (UMLS CUI [2])
C0003873 (UMLS CUI [3])
C0024141 (UMLS CUI [4])
C1527336 (UMLS CUI [5,1])
C0175668 (UMLS CUI [5,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial